Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPSIPB for Post-Mastectomy Pain
NCT05972083Completed
- Sponsor
- Istanbul Medipol University
- Start
- Aug 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Numerical Rating Scale (NRS) Pain Scores at 24 hours. Started Aug 2023; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05972083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05972083.